Cargando…
Mechanisms of Immunosuppression in Colorectal Cancer
SIMPLE SUMMARY: More emerging studies are exploring immunotherapy for solid cancers, including colorectal cancer. Besides, checkpoint blockade immunotherapy and chimeric antigen receptor (CAR) -based immune cell therapy have being examined in clinical trials for colorectal cancer patients. However,...
Autores principales: | Zhang, Yang, Rajput, Ashwani, Jin, Ning, Wang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766388/ https://www.ncbi.nlm.nih.gov/pubmed/33419310 http://dx.doi.org/10.3390/cancers12123850 |
Ejemplares similares
-
Oral-Intestinal Microbiota in Colorectal Cancer: Inflammation and Immunosuppression
por: Mo, Sisi, et al.
Publicado: (2022) -
The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
por: Mohd Salim, Nurul Hakimah, et al.
Publicado: (2023) -
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
por: Lu, Weiqiang, et al.
Publicado: (2020) -
MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
por: Vanhaver, Christophe, et al.
Publicado: (2021) -
Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer
por: Rajput, Ashwani, et al.
Publicado: (2013)